2018 Innovation in Medical Cannabis Therapies Symposium

On Nov. 9, 2018, GB Sciences invited top innovators in cannabis tech, biotech, nanotech, and metabolomics to a collaborative discussion designed to explore the necessary advances across multiple fields required for the development of safe and effective plant-based medicines.

Full List of Symposium Speakers and Bios

CLICK HERE for speaker biographies and information about participants in this year’s symposium

11:20am to 12:00pm — CULTIVATION: THE PLANT AS A MEDICINE

  • For many patients, dried flower is their medicine (sleeping, appetite, anti-anxiety, etc.)
  • What combination of techniques and technologies help to ensure safety and consistency from batch to batch?
  • What can be done to improve upon the current industry standards?

Dr. Philip Elzer (Executive Assoc. Dean, LSU Ag Center)

Dr. Ulrich Reimann-Philipp (Lead Botanist, GB Sciences Louisiana)

Brent Perkins (President & COO, Scynce LED)

Dani Fontaine (Colorado Hemp Project)

Steve Joyner (Quantum Shop)

2:35pm to 3:15pm — CLINICAL TRIALS: Challenges & Opportunities

  • Challenges/Opportunities through the US FDA versus International Clinical Trials
  • US FDA Process = FDA, DEA, and NIDA; Sole Source of Medical Cannabis from Ole Miss
  • US Trials done under State Cannabis Programs versus Federal FDA-Registration (Pros/Cons)

Dr. Carlos Rios-Bedoya (McLaren Health)

Dr. Ziva Cooper (Columbia University)

Dr. Michael Murphy (Founder, World Wide Clinical)

Dr. Amrit Seetharam (CurAccel)

3:35pm to 4:05pm — LEGISLATIVE: Need for industry involvement in driving positive change.

  • What areas could be improved, potentially state-by-state, to enhance the effectiveness of Cannabis Research and legitimization of Cannabis as Medicine?
  • Challenges/Opportunities through the US FDA versus International Clinical Trials
  • US FDA Process = FDA, DEA, and NIDA; Sole Source of Medical Cannabis from Ole Miss
  • US Trials done under State Cannabis Programs versus Federal FDA-Registration (Pros/Cons)

Elizabeth Ashford (Founder, Ceres Strategies)

Richard S. “Tick” Segerblom (Nevada State Senator)

John Davis (President, GB Sciences Louisiana)

Sandra Tiffany (Owner, GWGA, LLC and former Nevada State Senator)

4:45pm to 5:00pm TAKE-AWAYS FROM THE EVENT

Dr. Michael Farley, Valor Management, S.A.